Dr. Veena Agarwal
Dr Veena Agarwal is the Vice President of Oncology at Bioxcel Therapeutics Incorporation, New Haven, CT, USA, and is heading its’ India unit, based in Gurugram, India. Her work is focused on discovery and development of cancer molecules.
Dr Agarwal has more than 30 years of experience in research and development in the area of cancer, diabetes and inflammation.
Dr Veena earned a Ph. D. degree from Central Drug Research Institute, Lucknow, and went to US for further training. She has worked at National Institute of Health, Bethesda, Maryland, and UT South Western Medical Centre, Dallas, Texas USA. After being in academics for many years, she joined pharmaceutical Industry. She worked in the oncology area at Bayer Pharmaceuticals, and Ligand Pharmaceuticals, USA.
After spending 17 years in USA, she came back to India in 2005. She worked at Jubilant Biosys, Bangaluru, and Piramal Healthcare, Mumbai as Vice President and Senior Vice President respectively for ten years.
Dr. Agarwal has made significant contributions in the R & D phase of two marketed cancer drugs–Nexavar at Bayer and Bexarotene at Ligand. She has played a key role in setting up the R & D facility of Jubilant Biosys Ltd, Bangaluru and Patanjali Research Centre, Haridwar. She has published about 40 articles in International science journals, and is author on several patents. Veena is the recipient of several awards and honors in USA and India.